Bin Liu, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Bin Liu, PhD

Professor, Department of Anesthesia, UCSF

liub@anesthesia.ucsf.edu

Phone: (415) 206-6973 (voice)
Box 1371, UCSF
San Francisco, CA 94110-1371

View on UCSF Profiles

Cancer Center Membership

Program Member » Developmental Therapeutics

Additional Websites


Education

Princeton University, B.A., June 1990, Molecular Biology and Biochemical Sciences
University of California, San Francisco, Ph.D., Dec. 1994, Biochemistry and Biophysics


Professional Experience

  • 1995-1997
    Visiting fellow, Department of Dermatology, University of California school of medicine, San Francisco, California
  • 1998-2001
    Visiting fellow, Department of Anesthesia and Pharmaceutical chemistry, San Francisco General Hospital, San Francisco, California.
  • 2002-2006
    Assistant Professor, Department of Anesthesia, University of California, San Francisco.
  • 2006-2011
    Associate Professor, Department of Anesthesia, University of California, San Francisco.
  • 2011-present
    Professor, Department of Anesthesia, University of California, San Francisco.
  • 2003-present
    Program member, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.

Honors & Awards

  • 1990
    Summa Cum Laude (Princeton University)
  • 1990
    Phi Beta Kappa (Princeton University)
  • 1990
    Sigma Xi (Princeton University)
  • 1990
    Sigma Xi Book Award (Princeton University)
  • 1990
    E.R. Squibb and Sons Thesis Prize (Princeton University)
  • 1990
    George Khoury’65 Prize For Academic Excellence (Princeton University)
  • 1990,1991
    Regents’ Fellow (University of California at San Francisco)
  • 1994
    Chancellor's Fellow (University of California at San Francisco)
  • 1996-1999
    SmithKline Beecham Fellow of the Life Sciences Research Foundation
  • 1998
    Scleroderma Research Foundation investigator award
  • 2002
    American Cancer Society intramural research award
  • 2002
    BioSTAR/UC Discovery award
  • 2002
    CaPCure research award
  • 2002
    DOD New Investigator award
  • 2004
    MARF Investigator award
  • 2006
    MARF Investigator award
  • 2008
    AACR PanCan Pilot award
  • 2009
    UC Discovery SEED award
  • 2011
    MARF Investigator award

Selected Publications

  1. Bidlingmaier S, Su Y, Liu B. Combining Phage and Yeast Cell Surface Antibody Display to Identify Novel Cell Type-Selective Internalizing Human Monoclonal Antibodies. Methods Mol Biol. 2015; 1319:51-63.
    View on PubMed
  2. Bidlingmaier S, Liu B. Utilizing Yeast Surface Human Proteome Display Libraries to Identify Small Molecule-Protein Interactions. Methods Mol Biol. 2015; 1319:203-14.
    View on PubMed
  3. Bidlingmaier S, Liu B. Identification of Novel Protein-Ligand Interactions by Exon Microarray Analysis of Yeast Surface Displayed cDNA Library Selection Outputs. Methods Mol Biol. 2015; 1319:179-92.
    View on PubMed
  4. Bidlingmaier S, Liu B. Identification of Posttranslational Modification-Dependent Protein Interactions Using Yeast Surface Displayed Human Proteome Libraries. Methods Mol Biol. 2015; 1319:193-202.
    View on PubMed
  5. Sherbenou DW, Behrens CR, Su Y, Wolf JL, Martin TG, Liu B. The development of potential antibody-based therapies for myeloma. Blood Rev. 2015 Mar; 29(2):81-91.
    View on PubMed
  6. Ha KD, Bidlingmaier SM, Zhang Y, Su Y, Liu B. High-content Analysis of Antibody Phage-display Library Selection Outputs Identifies Tumor Selective Macropinocytosis-dependent Rapidly Internalizing Antibodies. Mol Cell Proteomics. 2014 Dec; 13(12):3320-31.
    View on PubMed
  7. Federman N, Chan J, Nagy JO, Landaw EM, McCabe K, Wu AM, Triche T, Kang H, Liu B, Marks JD, Denny CT. Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor. Sarcoma. 2012; 2012:126906.
    View on PubMed
  8. McCabe KE, Liu B, Marks JD, Tomlinson JS, Wu H, Wu AM. An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors. Mol Imaging Biol. 2012 Jun; 14(3):336-47.
    View on PubMed
  9. Iyer AK, Lan X, Zhu X, Su Y, Feng J, Zhang X, Gao D, Seo Y, Vanbrocklin HF, Broaddus VC, Liu B, He J. Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas. Cancer Res. 2011 Apr 1; 71(7):2428-32.
    View on PubMed
  10. Iyer AK, Su Y, Feng J, Lan X, Zhu X, Liu Y, Gao D, Seo Y, Vanbrocklin HF, Courtney Broaddus V, Liu B, He J. The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma. Biomaterials. 2011 Apr; 32(10):2605-13.
    View on PubMed
  11. Bidlingmaier S, Liu B. Identification of protein/target molecule interactions using yeast surface-displayed cDNA libraries. Methods Mol Biol. 2011; 729:211-23.
    View on PubMed
  12. Bidlingmaier S, Liu B. Construction of yeast surface-displayed cDNA libraries. Methods Mol Biol. 2011; 729:199-210.
    View on PubMed
  13. Bidlingmaier S, Wang Y, Liu Y, Zhang N, Liu B. Comprehensive analysis of yeast surface displayed cDNA library selection outputs by exon microarray to identify novel protein-ligand interactions. Mol Cell Proteomics. 2011 Mar; 10(3):M110.005116.
    View on PubMed
  14. Chen Y, Zhu X, Zhang X, Liu B, Huang L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther. 2010 Sep; 18(9):1650-6.
    View on PubMed
  15. Zhu X, Bidlingmaier S, Hashizume R, James CD, Berger MS, Liu B. Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells. Mol Cancer Ther. 2010 Jul; 9(7):2131-41.
    View on PubMed
  16. He J, Wang Y, Feng J, Zhu X, Lan X, Iyer AK, Zhang N, Seo Y, VanBrocklin HF, Liu B. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. J Nucl Med. 2010 Mar; 51(3):427-32.
    View on PubMed
  17. Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, Gabriel BS, Hann B, Liu B, Park JW, Hong K, Benz CC, Marks JD, Kirpotin DB. Development of a highly stable and targetable nanoliposomal formulation of topotecan. J Control Release. 2010 Jan 4; 141(1):13-21.
    View on PubMed
  18. Conrad F, Zhu X, Zhang X, Chalkley RJ, Burlingame AL, Marks JD, Liu B. Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion. J Mol Med (Berl). 2009 May; 87(5):507-14.
    View on PubMed
  19. Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B. Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res. 2009 Feb 15; 69(4):1570-7.
    View on PubMed
  20. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl). 2008 Sep; 86(9):1025-32.
    View on PubMed

Go to UCSF Profiles, powered by CTSI